LONDON MARKET OPEN: FTSE 100 sinks further as tariff fears grow
(Alliance News) - Stock prices in London slid further on Tuesday morning for the second day, as tariff threats from the US continued to unsettle investors. Read More
| Price | 1,795.50p on 20-01-2026 at 17:20:06 |
|---|---|
| Change | -20.50p -1.13% |
| Buy | 1,790.50p |
| Sell | 1,789.50p |
| Last Trade: | Unknown 900.00 at 1,795.50p |
| Day's Volume: | 7,498,670 |
| Last Close: | 1,795.50p |
| Open: | 1,802.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,774.00p - 1,805.50p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £72.43b |
| VWAP: | 1,795.27052p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 900 | 1,795.50p | OTC Trade |
17:12:12 - 20-Jan-26 |
| Buy* | 1,471 | 1,795.50p | SI Trade |
16:35:13 - 20-Jan-26 |
| Buy* | 3,224 | 1,795.50p | SI Trade |
16:35:13 - 20-Jan-26 |
| Sell* | 113 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 200 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 200 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 4 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 200 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 200 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
| Sell* | 2,650 | 1,795.50p | Automatic Execution |
16:35:13 - 20-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |